
A change from fingolimod to alemtuzumab caused significant disease activity in patients with MS.

A change from fingolimod to alemtuzumab caused significant disease activity in patients with MS.

Gut antibody imbalance may impact immune response to HIV.

Hypoxic tumor microenvironments influence the fate of disseminated tumor cells.

Top news of the day from across the health care landscape.

For patients with HIV, liver disease is a major cause of morbidity and mortality.

Do direct and indirect remuneration fees adversely affect the health care industry?

DIR fees continue to generate controversy for pharmacy stakeholders.

The prevalence of cirrhosis has increased by nearly 40% in patients with HCV.

Big data could allow physicians to take action before a patient with cancer needs to visit an emergency hospital.

Aerobic exercise increases hematologic indices in patients with RA.

African Americans with breast cancer have a 40% higher death rate than European-Americans.

Top news of the day from across the health care landscape.

Social media can identify behavioral trends and attitudes relevant to the risk of infection with HIV.

The interchangeability designation demonstrates that the efficacy and safety of a biosimilar is equal to the reference product.

With the entrance of more effective and less costly drugs, older treatments will likely decrease.

MicroRNAs could monitor the severity of MS in the future.

Common diabetes drug changes the biology of cancer cells.

Time of day is an important factor in chemotherapy-induced adverse events.

Pro-inflammatory cervicovaginal bacteria increased HIV risk more than 4-fold in women.

Top news of the day from across the health care landscape.

While nephrotoxicity associated with TDF has been well documented, prospective studies in HIV patients have been lacking.

The FDA recently accepted 2 new supplemental biologics license applications from Merck for pembrolizumab (Keytruda) in patients with bladder cancer.

Bristol-Myers Squibb Company recently announced that the FDA approved nivolumab (Opdivo) injection for patients with advanced or metastatic urothelial carcinoma.

Direct and indirect remuneration fees seen to increase costs for Medicare, beneficiaries, pharmacies, and taxpayers.

Study finds direct and indirect remuneration fees increase healthcare costs.

Smoking is a risk factor for breaking tolerance to multiple autoantigens in RA.

Findings may lead to preventative treatments for breast cancer, such as anti-inflammatory drugs.

HCV rates 3 times higher in patients with lupus.

Top news of the day from across the health care landscape.